N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide

C182H206N28O14 — CID 160657271

IUPACN-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide
SMILESCC(=O)Nc1ccc2nc(-c3ccc(NC(=O)C4CCCC4)cc3)[nH]c2c1.CC(=O)Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC5CCC4C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC5CCC4C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCC4)cc3)[nH]c2c1)C1CCCCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1)C1CCCCCC1
InChIInChI=1S/C30H34N4O2.C28H34N4O2.2C27H30N4O2.C27H32N4O2.C22H24N4O2.C21H22N4O2/c35-28(22-3-1-2-4-22)31-23-7-5-21(6-8-23)27-33-25-10-9-24(14-26(25)34-27)32-29(36)30-15-18-11-19(16-30)13-20(12-18)17-30;33-27(20-10-6-3-7-11-20)29-22-14-12-19(13-15-22)26-31-24-17-16-23(18-25(24)32-26)30-28(34)21-8-4-1-2-5-9-21;2*32-26(18-3-1-2-4-18)28-20-9-7-17(8-10-20)25-30-23-12-11-21(15-24(23)31-25)29-27(33)22-14-16-5-6-19(22)13-16;32-26(20-9-5-6-10-20)28-21-13-11-18(12-14-21)25-30-23-16-15-22(17-24(23)31-25)29-27(33)19-7-3-1-2-4-8-19;1-14(27)23-18-11-12-19-20(13-18)26-21(25-19)15-7-9-17(10-8-15)24-22(28)16-5-3-2-4-6-16;1-13(26)22-17-10-11-18-19(12-17)25-20(24-18)14-6-8-16(9-7-14)23-21(27)15-4-2-3-5-15/h5-10,14,18-20,22H,1-4,11-13,15-17H2,(H,31,35)(H,32,36)(H,33,34);12-18,20-21H,1-11H2,(H,29,33)(H,30,34)(H,31,32);2*7-12,15-16,18-19,22H,1-6,13-14H2,(H,28,32)(H,29,33)(H,30,31);11-17,19-20H,1-10H2,(H,28,32)(H,29,33)(H,30,31);7-13,16H,2-6H2,1H3,(H,23,27)(H,24,28)(H,25,26);6-12,15H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25)
InChIKeyRLFDOHZJDNQKJZ-UHFFFAOYSA-N
MW3009.83 g/mol
LogP39.93
Rot. Bonds33

About N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide

N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide (PubChem CID 160657271) has the molecular formula C182H206N28O14 and a molecular weight of 3009.83 g/mol. Its IUPAC name is N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide.

Molecular Properties

Compound NameN-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide
PubChem CID160657271
Molecular FormulaC182H206N28O14
Molecular Weight3009.83 g/mol
Exact Mass3007.63
IUPAC NameN-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide
SMILESCC(=O)Nc1ccc2nc(-c3ccc(NC(=O)C4CCCC4)cc3)[nH]c2c1.CC(=O)Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC5CCC4C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC5CCC4C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCC4)cc3)[nH]c2c1)C1CCCCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1)C1CCCCCC1
InChIInChI=1S/C30H34N4O2.C28H34N4O2.2C27H30N4O2.C27H32N4O2.C22H24N4O2.C21H22N4O2/c35-28(22-3-1-2-4-22)31-23-7-5-21(6-8-23)27-33-25-10-9-24(14-26(25)34-27)32-29(36)30-15-18-11-19(16-30)13-20(12-18)17-30;33-27(20-10-6-3-7-11-20)29-22-14-12-19(13-15-22)26-31-24-17-16-23(18-25(24)32-26)30-28(34)21-8-4-1-2-5-9-21;2*32-26(18-3-1-2-4-18)28-20-9-7-17(8-10-20)25-30-23-12-11-21(15-24(23)31-25)29-27(33)22-14-16-5-6-19(22)13-16;32-26(20-9-5-6-10-20)28-21-13-11-18(12-14-21)25-30-23-16-15-22(17-24(23)31-25)29-27(33)19-7-3-1-2-4-8-19;1-14(27)23-18-11-12-19-20(13-18)26-21(25-19)15-7-9-17(10-8-15)24-22(28)16-5-3-2-4-6-16;1-13(26)22-17-10-11-18-19(12-17)25-20(24-18)14-6-8-16(9-7-14)23-21(27)15-4-2-3-5-15/h5-10,14,18-20,22H,1-4,11-13,15-17H2,(H,31,35)(H,32,36)(H,33,34);12-18,20-21H,1-11H2,(H,29,33)(H,30,34)(H,31,32);2*7-12,15-16,18-19,22H,1-6,13-14H2,(H,28,32)(H,29,33)(H,30,31);11-17,19-20H,1-10H2,(H,28,32)(H,29,33)(H,30,31);7-13,16H,2-6H2,1H3,(H,23,27)(H,24,28)(H,25,26);6-12,15H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25)
InChIKeyRLFDOHZJDNQKJZ-UHFFFAOYSA-N
XLogP39.93
TPSA608.16 Ų
H-Bond Donors21
H-Bond Acceptors21
Rotatable Bonds33
Heavy Atoms224
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003009.83
LogP ≤ 539.93
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1021

Analyze N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide?
The IUPAC name of N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide (CID 160657271) is N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide.
What is the SMILES notation for N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide?
The canonical SMILES for N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide is CC(=O)Nc1ccc2nc(-c3ccc(NC(=O)C4CCCC4)cc3)[nH]c2c1.CC(=O)Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC5CCC4C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC5CCC4C5)cc3[nH]2)cc1)C1CCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCC4)cc3)[nH]c2c1)C1CCCCCC1.O=C(Nc1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1)C1CCCCCC1.
What is the InChIKey of N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide?
The InChIKey is RLFDOHZJDNQKJZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H34N4O2.C28H34N4O2.2C27H30N4O2.C27H32N4O2.C22H24N4O2.C21H22N4O2/c35-28(22-3-1-2-4-22)31-23-7-5-21(6-8-23)27-33-25-10-9-24(14-26(25)34-27)32-29(36)30-15-18-11-19(16-30)13-20(12-18)17-30;33-27(20-10-6-3-7-11-20)29-22-14-12-19(13-15-22)26-31-24-17-16-23(18-25(24)32-26)30-28(34)21-8-4-1-2-5-9-21;2*32-26(18-3-1-2-4-18)28-20-9-7-17(8-10-20)25-30-23-12-11-21(15-24(23)31-25)29-27(33)22-14-16-5-6-19(22)13-16;32-26(20-9-5-6-10-20)28-21-13-11-18(12-14-21)25-30-23-16-15-22(17-24(23)31-25)29-27(33)19-7-3-1-2-4-8-19;1-14(27)23-18-11-12-19-20(13-18)26-21(25-19)15-7-9-17(10-8-15)24-22(28)16-5-3-2-4-6-16;1-13(26)22-17-10-11-18-19(12-17)25-20(24-18)14-6-8-16(9-7-14)23-21(27)15-4-2-3-5-15/h5-10,14,18-20,22H,1-4,11-13,15-17H2,(H,31,35)(H,32,36)(H,33,34);12-18,20-21H,1-11H2,(H,29,33)(H,30,34)(H,31,32);2*7-12,15-16,18-19,22H,1-6,13-14H2,(H,28,32)(H,29,33)(H,30,31);11-17,19-20H,1-10H2,(H,28,32)(H,29,33)(H,30,31);7-13,16H,2-6H2,1H3,(H,23,27)(H,24,28)(H,25,26);6-12,15H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25).
What are the key properties of N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide?
N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide has a molecular weight of 3009.83 g/mol, XLogP of 39.93, 33 rotatable bonds, 21 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide is sourced from PubChem (CID 160657271), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).